There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Titan Medical Inc (TMDI) and Clearside Biomedical (CLSD) with bullish sentiments.
Titan Medical Inc (TMDI)
In a report released today, Suraj Kalia from Northland Securities maintained a Buy rating on Titan Medical Inc, with a price target of $6. The company’s shares opened today at $2.17.
Kalia commented:
“We waited to have a call with management, and our summary underneath is a reflection of the information gleaned from our conversation.”
According to TipRanks.com, Kalia is a 5-star analyst with an average return of 11.1% and a 59.3% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Varex Imaging Corporation, and Strata Skin Sciences Inc.
Titan Medical Inc has an analyst consensus of Strong Buy, with a price target consensus of $5.33.
See today’s analyst top recommended stocks >>
Clearside Biomedical (CLSD)
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Clearside Biomedical, with a price target of $4. The company’s shares opened today at $1.17, close to its 52-week low of $0.95.
According to TipRanks.com, Moussatos ‘ ranking currently consits of no stars on a 0-5 ranking scale, with an average return of -9.4% and a 30.5% success rate. Moussatos covers the Healthcare sector, focusing on stocks such as BioMarin Pharmaceutical Inc., Aquestive Therapeutics Inc, and Allena Pharmaceuticals Inc.
Clearside Biomedical has an analyst consensus of Moderate Buy, with a price target consensus of $4.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
